EXCLUSIVE: Industry training platform Stage 32 has revealed the 11 finalists selected for its inaugural Empowering Women Script Competition, running in collaboration with production company Catalyst ...

TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts and reports updated rates of response and disease ...